Application Provides Discovery, Collaboration, and Business Intelligence Tools
By MedImaging International staff writers Posted on 05 Feb 2009 |
Zassi Medical Evolutions (Fernandina Beach, FL, USA) recently announced the launch of e-Zassi an online community, which provides powerful efficiencies to the medical device industry by streamlining diligence, collaboration, and discovery of new medical technologies and industry participants with an exclusive range of intelligent web-based applications.
In development for several years, e-Zassi.com has been designed to extract critical technical- and business-related traits and attributes from technologies, organizations, and individuals within the medical device-specific community. This "business DNA” can then be utilized to increase search/match relevancy and materially enhance success rates and lower costs.
E-Zassi's proprietary Deep DNA (Device Network Attributes) profiling technology captures in-depth and highly relevant search criteria on the proficiencies, preferences, and targeted areas for development of individuals and organizations. The company believes that allowing members to leverage these vital attributes to enable collaboration in the medical device sector will lower costs and create efficiencies; as these capabilities are not typically identified or utilized by existing broad, conventional business networks or search engines.
Available by subscription, e-Zassi members will have 24/7 access to a variety of modules including the world's first Innovation Assessment software platform. This platform allows members to deeply analyze and profile medical technologies via a simple to use question and answer process. Remarkably, the program utilizes no confidential information to generate powerful development and commercially related outputs that are critical to activities such as: technology transfer; business development; market and commercial analysis; due diligence; intellectual property and patent development; and product development and financial planning.
The company recognizes the value provided by the ability to gain insights earlier in the innovation, development, and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution, and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system provides this decision support knowledge in minutes providing great value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund, or provide services for medical technologies.
"The [US]$250 billion global medical device industry invests more than $40 billion annually in new product innovation and development alone. As such, it requires rapid decision-making, comprehensive planning, and increased efficiency in terms of technology due diligence, business networking, and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost-effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA-based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise,” stated Peter M. von Dyck, e-Zassi's founder and chief executive officer.
Related Links:
Zassi Medical Evolutions
In development for several years, e-Zassi.com has been designed to extract critical technical- and business-related traits and attributes from technologies, organizations, and individuals within the medical device-specific community. This "business DNA” can then be utilized to increase search/match relevancy and materially enhance success rates and lower costs.
E-Zassi's proprietary Deep DNA (Device Network Attributes) profiling technology captures in-depth and highly relevant search criteria on the proficiencies, preferences, and targeted areas for development of individuals and organizations. The company believes that allowing members to leverage these vital attributes to enable collaboration in the medical device sector will lower costs and create efficiencies; as these capabilities are not typically identified or utilized by existing broad, conventional business networks or search engines.
Available by subscription, e-Zassi members will have 24/7 access to a variety of modules including the world's first Innovation Assessment software platform. This platform allows members to deeply analyze and profile medical technologies via a simple to use question and answer process. Remarkably, the program utilizes no confidential information to generate powerful development and commercially related outputs that are critical to activities such as: technology transfer; business development; market and commercial analysis; due diligence; intellectual property and patent development; and product development and financial planning.
The company recognizes the value provided by the ability to gain insights earlier in the innovation, development, and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution, and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system provides this decision support knowledge in minutes providing great value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund, or provide services for medical technologies.
"The [US]$250 billion global medical device industry invests more than $40 billion annually in new product innovation and development alone. As such, it requires rapid decision-making, comprehensive planning, and increased efficiency in terms of technology due diligence, business networking, and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost-effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA-based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise,” stated Peter M. von Dyck, e-Zassi's founder and chief executive officer.
Related Links:
Zassi Medical Evolutions
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans
A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable
Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read moreUltrasound
view channel
New Incision-Free Technique Halts Growth of Debilitating Brain Lesions
Cerebral cavernous malformations (CCMs), also known as cavernomas, are abnormal clusters of blood vessels that can grow in the brain, spinal cord, or other parts of the body. While most cases remain asymptomatic,... Read more.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read moreNuclear Medicine
view channel
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read more
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read moreGeneral/Advanced Imaging
view channel
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more